Evidence map›Paper›PMID 41984349›Full record

ArticleClinical rheumatology2026

Clinical analysis of osteonecrosis of the jaw in patients with rheumatoid arthritis: risk factors and oral health implications.

Hiroko Nagafuchi, Takayasu Ando, Yutaka Goto, Kimito Kawahata

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hiroko NagafuchiDepartment of Rheumatology and Allergology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan. h3naga@marianna-u.ac.jp.ORCID http://orcid.org/0000-0002-4926-3528
Takayasu AndoDepartment of Rheumatology and Allergology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.ORCID http://orcid.org/0000-0002-1802-5092
Yutaka GotoDepartment of Rheumatology and Allergology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.ORCID http://orcid.org/0000-0003-2944-3860
Kimito KawahataDepartment of Rheumatology and Allergology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, 216-8511, Japan.ORCID http://orcid.org/0000-0002-4359-9987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION/

objectivesOsteonecrosis of the jaw (ONJ) is a rare but serious complication in patients with rheumatoid arthritis (RA), and its risk factors remain unclear. This study aimed to clarify the clinical characteristics and risk factors for ONJ in patients with RA.

methodsWe retrospectively analyzed 35 patients with RA who developed ONJ against 276 control patients with RA who received collaborative medical-dental care but did not develop ONJ. Group comparisons were performed using Mann-Whitney U and Fisher's exact tests; logistic regression was performed to determine the risk factors (significance set at p < 0.05).

resultsUnivariate analysis revealed that the ONJ group exhibited a higher prevalence of rheumatoid factor positivity (p = 0.021), advanced RA (Steinbrocker stage III-IV; p < 0.0001), osteoporosis (p < 0.0001), low body mass index (< 18.5; p = 0.041), dental infections (p = 0.011), and regular use of nonsteroidal anti-inflammatory drugs (p = 0.004). The use of bone resorption inhibitors was also higher in the ONJ group (p < 0.0001), particularly for treatment rather than prevention (p = 0.020). Multivariate analysis identified osteoporosis (OR 7.82, 95% CI 7.21-8.48, p < 0.001), dental infection (OR 2.25, 95% CI 2.07-2.45, p < 0.001), and advanced stage of RA (OR 4.10, 95% CI 3.68-4.56, p < 0.001) as independent risk factors for ONJ.

conclusionsONJ in patients with RA arises from synergistic effects of osteoporosis, advanced joint destruction, and dental infection. Clinicians should focus on identifying high-risk patients based on RA severity (Steinbrocker stage III-IV) and managing modifiable factors through close medical-dental collaboration to prevent ONJ. Key Points • This retrospective study compared 35 patients with rheumatoid arthritis (RA) who developed osteonecrosis of the jaw (ONJ) with 276 patients with RA who received dental treatment but did not develop ONJ. • Osteoporosis, advanced joint destruction, and dental infection were identified as independent risk factors for ONJ in patients with RA. • Differences in the nutritional and disease profiles were observed: hypoalbuminemia was more frequent in the control group, whereas a low body mass index was more common in the ONJ group. • Collaboration between rheumatologists and dental professionals is crucial for preventing ONJ, maintaining oral function, and supporting the overall health of older adults with RA.

Indexed as

Arthritis, RheumatoidOral HealthAdultAgedAnti-Inflammatory Agents, Non-SteroidalFemaleHumansLogistic ModelsMaleMiddle AgedOsteoporosisRetrospective StudiesRisk FactorsAnti-Inflammatory Agents, Non-SteroidalDental infectionJoint destructionOsteonecrosis of the jawOsteoporosisRheumatoid arthritis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.